Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
megestrol acetate + rosuvastatin
- Development stage
- Phase 3
- Lead developer
- Fudan University
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Megestrol acetate + rosuvastatin is a combination therapy being investigated by the Obstetrics and Gynecology Hospital of Fudan University for fertility-preserving treatment in young women with atypical endometrial hyperplasia (AEH) and dyslipidemia. The regimen consists of megestrol acetate, a synthetic progestational agent that acts as a progesterone receptor agonist to induce endometrial differentiation and reverse hyperplasia, and rosuvastatin, a small molecule statin that inhibits HMG-CoA reductase to lower cholesterol levels. This combination is based on the rationale that dyslipidemia is prevalent in AEH patients and that managing metabolic health with rosuvastatin can improve the clinical efficacy of progestin therapy, offering a potential fertility-sparing alternative to hysterectomy.
- Other names
- Megestrol acetate plus rosuvastatin
02
Targets
HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)PR (Progesterone receptor)
Beyond the preview
Go deeper on megestrol acetate + rosuvastatin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on megestrol acetate + rosuvastatin.